The "e" is for our Enterprises! Learn more about New York Blood Center Enterprises' lifesaving blood products & services, world-class research institute, education resources, job opportunities, and more!
The deferral for potential exposure to Mad Cow Disease (vCJD) has been lifted! Those who spent time in the UK, France or Ireland may now be eligible to donate.
The need for blood donations remains urgent. Type O, Rh negative, and platelet donors are especially critical right now.
Do you want a career you'll love and be proud of? Join the team at NYBC! We're looking for enthusiastic candidates for phlebotomy and laboratory careers.
According to Cooley's Anemia Foundation (CAF), "these Fellowship recipients were assessed on the basis of the quality of the scientific content,
Dr. Hillyer's research has dramatically altered healthcare, including the way we collect cells used for bone marrow transplantation
Should You Consider a New Reference Laboratory? Learn how an immunohematology reference laboratory can help
NYBC has a long-standing commitment to patients with sickle cell disease, serving transfusion needs
An important message from Suffolk County Legislator Jason Richberg
Dr. Asim K. Debnath, Head of the Laboratory of Molecular Modeling and Drug Design
Specialized lab services require qualified staff and expensive equipment and reagents.
Many congratulations to NYBC Enterprises President and CEO Christopher D. Hillyer, MD
The study enrolls its 1st participants in trial using mRNA technology developed for the COVID-19 vaccine
The prestigious grant totaling $6.3M was awarded to Dr. Yazdanbakhsh for her exceptional research in sickle cell disease and transfusion therapy
NYBC investigators discovered a set of novel small-molecule pancoronavirus fusion inhibitors.
The American Society of Hematology (ASH), the world’s largest professional society concerned with the causes and treatment of blood disorders...
The grant will be used to complete a five-year research project...
Congratulations to Connie Westhoff, PhD, NYBCe Executive Scientific Director, Immunohematology...
To recruit donors at this critical time, NYBC launches “Pint for a Pint”
Recent results of the AMP trials showed the feasibility of blocking HIV with bimonthly infusions of broadly neutralizing monoclonal antibodies.
According to existing research, the vaccines create enough antibodies to fight the disease
The new building will anchor and grow NYC’s life science ecosystem
We are very pleased to acknowledge the revised FDA guidelines addressing the urgent need for blood during the COVID-19 pandemic.
Fox 5 Good Day NY's recent segment highlighted the lifesaving power of convalescent plasma donation for critical COVID-19 patients.
Study shows the potential of plasma infusions to help save the lives of critically ill COVID-19 patients.
The grant will fund research into the impact of transfusions in patients with sickle cell disease and how to improve transfusion management.
You can support our mission instantly by Texting 'NYBC' or 'RESEARCH' to 20222 to donate $25 Now!